| Unique ID issued by UMIN | UMIN000062352 |
|---|---|
| Receipt number | R000071359 |
| Scientific Title | An exploratory interventional study on the association between hydrogen nanobubble water intake and exercise performance indices during a cycling exercise task |
| Date of disclosure of the study information | 2026/07/28 |
| Last modified on | 2026/07/27 15:49:43 |
A study on cycling exercise performance and perceived fatigue after drinking hydrogen nanobubble water
HNW-CYCLE Study
An exploratory interventional study on the association between hydrogen nanobubble water intake and exercise performance indices during a cycling exercise task
HNW-CYCLE Trial
| Japan |
Healthy adults (no specific disease targeted)
| Rehabilitation medicine | Adult |
Others
NO
To explore, in healthy adults, the association between hydrogen nanobubble water (HNW) intake and exercise performance indices (such as distance covered) and subjective burden during a 20-minute cycling exercise task, by comparing an HNW condition with an ordinary drinking water condition in a randomized crossover design. Participants are blinded to the allocated beverage condition (single blind). No invasive examinations such as blood sampling are performed.
Others
Exploratory investigation of the association between hydrogen nanobubble water intake and exercise performance indices and subjective burden during a cycling exercise task
Exploratory
Explanatory
Not applicable
Distance covered (m) during the latter 10 minutes of the 20-minute cycling task, recorded from the cycle ergometer (POWER MAX V3 CONNECT) display at the end of exercise on each measurement day, and compared between the hydrogen nanobubble water condition and the ordinary drinking water condition.
1. Distance covered (m) over the entire 20-minute cycling task and during the first 10 minutes (at the end of exercise)
2. Mean pedaling cadence (rpm) and workload setting (kp) during exercise
3. Heart rate (bpm) at rest (before start), after the 5-minute warm-up, at 10 minutes into the main task, and immediately after the task
4. Percutaneous oxygen saturation (SpO2, %) at the same four time points
5. Rating of perceived exertion (Borg RPE, 6-20) at the same four time points and at the end of exercise
6. Blood pressure (mmHg) at rest before the start of measurement
7. Subjective symptoms questionnaire (Jikakusho shirabe; 25 items, 5-point scale): individual items and total score, before and after exercise
8. Fatigue site questionnaire (17 body regions, 4-point scale 0-3): individual regions and total score, before and after exercise
9. Body composition (body weight, body fat percentage, skeletal muscle mass, etc.; InBody270) at enrollment or on a measurement day, as background information
10. Occurrence and reason for discontinuation of exercise, and occurrence of adverse events or changes in physical condition, on each measurement day
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Prevention
| Food |
Hydrogen nanobubble water (HNW) condition: On the measurement day, participants ingest a total of 500 mL of hydrogen nanobubble water (Hydrogen NanoGAS Water, Symbiosis Co., Ltd.). Of this, 250 mL is ingested before the start of the cycling task, and the remaining 250 mL is ingested during the 5-minute warm-up and over the first 10 minutes of the 20-minute main cycling task. The beverage is dispensed into identical unlabeled containers identified only by container number, so that participants are not informed of the beverage condition on that measurement day. Volume, temperature, and container are matched to the ordinary drinking water condition. Time of ingestion, volume ingested, and any change in physical condition after ingestion are recorded. The intervention is a single-dose administration on one measurement day, with a 3-7 day interval between this condition and the ordinary drinking water condition.
Ordinary drinking water condition (control): On the measurement day, participants ingest a total of 500 mL of ordinary drinking water. Volume, timing, temperature, and container are identical to the HNW condition; the beverage is dispensed into identical unlabeled containers identified only by container number. Time of ingestion, volume ingested, and any change in physical condition after ingestion are recorded. The intervention is a single-dose administration on one measurement day, with a 3-7 day interval from the HNW condition.
Exercise task common to both conditions: Using a cycle ergometer (POWER MAX V3 CONNECT, Konami Sports Co., Ltd.), participants perform a 5-minute warm-up at a workload of 1 kp, followed by 20 minutes of cycling at a workload set in kp using body weight (kg) x 0.035 as a guide. Participants are instructed to continue exercising within the range they themselves judge sustainable for 20 minutes; forced continuation is not required. A 5-minute cool-down at low workload follows. Participants refrain from high-intensity exercise for 24-48 hours before measurement and from food intake for 3 hours before measurement; caffeine intake is also matched between conditions as far as possible.
| 18 | years-old | <= |
| 65 | years-old | > |
Male and Female
Participants must meet all of the following
1. Students or faculty/staff enrolled at R Professional University of Rehabilitation
2. Aged 18 years or older and under 65 years
3. Able to understand the study and provide written informed consent of their own free will
4. Judged able to safely perform the cycling exercise task
5. Able to comply with the pre-measurement standardization (avoiding high-intensity exercise for 24-48 hours before measurement, fasting for 3 hours before measurement, etc.) and to attend two measurement sessions separated by 3-7 days
Participants meeting any of the following are excluded
1. Those judged unable to safely perform the cycling exercise task due to cardiovascular, respiratory, or orthopedic disease
2. Those judged, by self-report or prior confirmation, as possibly having symptoms aggravated by exercise
3. Those under exercise restriction by a physician
4. Those with poor physical condition on the measurement day (fever, marked fatigue, dizziness, nausea, chest discomfort, etc.)
5. Those with difficulty understanding the study procedures
6. Those judged by the principal investigator to be unsuitable for participation for any other reason
30
| 1st name | Sechang |
| Middle name | |
| Last name | Oh |
R Professional University of Rehabilitation
Department of Physical Therapy, Faculty of Rehabilitation
300-0032
2-10-35 Kohoku, Tsuchiura, Ibaraki 300-0032, Japan
029-824-7611
o-sechan@u.a-ru.ac.jp
| 1st name | Sechang |
| Middle name | |
| Last name | Oh |
R Professional University of Rehabilitation
Department of Physical Therapy, Faculty of Rehabilitation
300-0032
2-10-35 Kohoku, Tsuchiura, Ibaraki 300-0032, Japan
029-824-7611
o-sechan@u.a-ru.ac.jp
R Professional University Of Rehabilitation
R Professional University Of Rehabilitation
Self funding
Japan
KAKENHI, Grant-in-Aid for Scientific Research (C)); R Professional University Of Rehabilitation, institutional research funds; Oriental Shiraishi Corporation, scholarship donation
Research Ethics Review Committee, R Professional University Of Rehabilitation
2-10-35 Kohoku, Tsuchiura, Ibaraki 300-0032, Japan
029-824-7611
k-rinri@a-ru.ac.jp
NO
アール医療専門職大学(茨城県)
| 2026 | Year | 07 | Month | 28 | Day |
Unpublished
Individual participant data will not be made publicly available.
Individual participant data collected in this study will be managed within the scope of the research protocol and the informed consent obtained from participants, and there is no plan for public release. Data are coded so that individuals cannot be identified, managed by the principal investigator, and retained for 10 years after the end of the study period. Results will be published only in statistically aggregated form. Inquiries for academic purposes will be considered individually by the principal investigator and, where necessary, addressed after approval by the research ethics review committee.
Preinitiation
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 07 | Month | 07 | Day |
| 2026 | Year | 07 | Month | 28 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2027 | Year | 04 | Month | 30 | Day |
| 2027 | Year | 05 | Month | 31 | Day |
| 2027 | Year | 07 | Month | 31 | Day |
This study was planned based on a preliminary examination of 11 participants conducted at our institution. In that examination, the distance covered during the latter 10 minutes of the cycling task was compared between the ordinary drinking water condition and the hydrogen nanobubble water condition, yielding an effect size of Cohen's dz = 1.00. Because this was a small preliminary examination and the effect size may have been overestimated, a more conservative dz = 0.55 was used for sample size calculation in the present study.
The order of conditions is randomly allocated using a randomization list generated with random numbers by an allocation manager who is not involved in the measurements, so that the number of participants in each order sequence is balanced. Beverages are dispensed into identical unlabeled containers identified only by container number, so that participants are not informed of the beverage condition on that measurement day.
No invasive examinations such as blood sampling are performed in this study. The study is conducted with the approval of the Research Ethics Review Committee of R Professional University Of Rehabilitation.
| 2026 | Year | 07 | Month | 27 | Day |
| 2026 | Year | 07 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071359